Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism

Ying, Haoqiang, Kimmelman, Alec C., Lyssiotis, Costas A., Hua, Sujun, Chu, Gerald C., Fletcher-Sananikone, Eliot, Locasale, Jason W., Son, Jaekyoung +23 more·2012·Cell

Cited by (1,006)

Items 101–200 of 1,006

  1. Metabolic Pathways Regulating Colorectal Cancer Initiation and Progression
    La Vecchia, Sofia, Sebastián, Carlos · 2020 · Seminars in Cell & Developmental Biology
  2. Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer
    Neha M. Akella, Lorela Ciraku, Mauricio J. Reginato · 2019 · BMC Biology
  3. Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer
    Aftab Alam, Eric Levanduski, Parker J. Denz, Helena Solleiro Villavicencio, Maulasri Bhatta, Lamees Alhorebi, Yali Zhang, Eduardo Cortes Gomez, Brian G. Morreale, Sharon Senchanthisai et al. · 2022 · Cancer Cell
  4. Understanding metabolic regulation and its influence on cell physiology
    Metallo, Christian M., Vander Heiden, Matthew G. · 2013 · Molecular Cell
  5. The molecular biology of pancreatic adenocarcinoma: Translational challenges and clinical perspectives
    Wang, Shun, Zheng, Yan, Yang, Feng, Zhu, Le, Zhu, Xiao-Qiang, Wang, Zhe-Fang, Wu, Xiao-Lin, Zhou, Cheng-Hui, Yan, Jia-Yan, Hu, Bei-Yuan et al. · 2021 · Signal Transduction and Targeted Therapy
  6. Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation
    Tape, Christopher J., Ling, Stephanie, Dimitriadi, Maria, McMahon, Kelly M., Worboys, Jonathan D., Leong, Hui Sun, Norrie, Ida C., Miller, Crispin J., Poulogiannis, George, Lauffenburger, Douglas A. et al. · 2016 · Cell
  7. The Significance of Mitochondrial Dysfunction in Cancer
    Yongde Luo, Jianjia Ma, Weiqin Lu · 2020 · International Journal of Molecular Sciences
  8. KRAS mutation in pancreatic cancer
    Luo, Ji · 2021 · Seminars in Oncology
  9. The metabolic landscape of RAS-driven cancers from biology to therapy
    Mukhopadhyay, Suman, Vander Heiden, Matthew G., McCormick, Frank · 2021 · Nature Cancer
  10. Chemical Similarity Enrichment Analysis (ChemRICH) as alternative to biochemical pathway mapping for metabolomic datasets
    Dinesh Kumar Barupal, Oliver Fiehn · 2017 · Scientific Reports
  11. Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers
    Mullarky, Edouard, Lucki, Natasha C., Beheshti Zavareh, Reza, Anglin, Justin L., Gomes, Ana P., Nicolay, Brandon N., Wong, Jenny C. Y., Christen, Stefan, Takahashi, Hidenori, Singh, Pradeep K. et al. · 2016 · Proceedings of the National Academy of Sciences
  12. Inflammation, Autophagy, and Obesity: Common Features in the Pathogenesis of Pancreatitis and Pancreatic Cancer
    Ilya Gukovsky, Ning Li, Jelena Todoric, Anna S. Gukovskaya, Michael Karin · 2013 · Gastroenterology
  13. Pancreatic cancer: why is it so hard to treat?
    Paul E. Oberstein, Kenneth P. Olive · 2013 · Therapeutic Advances in Gastroenterology
  14. New insights into pancreatic cancer-induced paraneoplastic diabetes
    Raghuwansh P. Sah, Sajan Jiv Singh Nagpal, Debabrata Mukhopadhyay, Suresh T. Chari · 2013 · Nature Reviews Gastroenterology & Hepatology
  15. Metabolic Codependencies in the Tumor Microenvironment
    Prasenjit Dey, Alec C. Kimmelman, Ronald Anthony DePinho · 2021 · Cancer Discovery
  16. KRAS as a Therapeutic Target
    McCormick, Frank · 2015 · Clinical Cancer Research
  17. Functional expression of sodium-glucose transporters in cancer
    Claudio Scafoglio, Bruce A. Hirayama, Vladimir Kepe, Jie Liu, Chiara Ghezzi, Nagichettiar Satyamurthy, Neda A. Moatamed, Jiaoti Huang, Hermann Koepsell, Jorge R. Barrio et al. · 2015 · Proceedings of the National Academy of Sciences
  18. Hypoxia‐inducing factors as master regulators of stemness properties and altered metabolism of cancer‐ and metastasis‐initiating cells
    Murielle Mimeault, Surinder K. Batra · 2013 · Journal of Cellular and Molecular Medicine
  19. Integration of lipidomics and metabolomics for in-depth understanding of cellular mechanism and disease progression
    Raoxu Wang, Bowen Li, Sin Man Lam, Guanghou Shui · 2019 · Journal of genetics and genomics/Journal of Genetics and Genomics
  20. Compensatory metabolic networks in pancreatic cancers upon perturbation of glutamine metabolism
    Biancur, Douglas E., Paulo, Joao A., Małachowska, Beata, Quiles Del Rey, Maria, Sousa, Cristovão M., Wang, Xiaoxu, Sohn, Albert S. W., Chu, Gerald C., Gygi, Steven P., Harper, J. Wade et al. · 2017 · Nature Communications
  21. Cell Surface Lactate Receptor GPR81 Is Crucial for Cancer Cell Survival
    Christina Lynn Roland, Thiruvengadam Arumugam, Defeng Deng, Shi He Liu, Bincy Philip, Sobeyda Gomez, William Reece Burns, Vijaya Ramachandran, Huamin Wang, Zobeida Cruz‐Monserrate et al. · 2014 · Cancer Research
  22. Interconnection between Metabolism and Cell Cycle in Cancer
    Philippe Icard, Ludovic Fournel, Zherui Wu, Marco Alifano, Hubert Lincet · 2019 · Trends in Biochemical Sciences
  23. T helper 17 cells play a critical pathogenic role in lung cancer
    Chang, Seon Hee, Mirabolfathinejad, Seyedeh Golsar, Katta, Harshadadevi, Cumpian, Amber M., Gong, Lei, Caetano, Mauricio S., Moghaddam, Seyed Javad, Dong, Chen · 2014 · Proceedings of the National Academy of Sciences
  24. The enhancement of glycolysis regulates pancreatic cancer metastasis
    Yang, Jinshou, Ren, Bo, Yang, Gang, Wang, Huanyu, Chen, Guangyu, You, Lei, Zhang, Taiping, Zhao, Yupei · 2020 · Cellular and Molecular Life Sciences
  25. Acetyl-CoA Metabolism Supports Multistep Pancreatic Tumorigenesis
    Carrer, Alessandro, Trefely, Sophie, Zhao, Steven, Campbell, Sydney L., Norgard, Robert J., Schultz, Kollin C., Sidoli, Simone, Parris, Joshua L.D., Affronti, Hayley C., Sivanand, Sharanya et al. · 2019 · Cancer Discovery
  26. Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities
    Emma M. Kerr, Edoardo Gaude, Frances K. Turrell, Christian Frezza, Carla P. Martins · 2016 · Nature
  27. α-Ketoglutarate links p53 to cell fate during tumour suppression
    Morris, John P., Yashinskie, Jossie J., Koche, Richard, Chandwani, Rohit, Tian, Sha, Chen, Chi-Chao, Baslan, Timour, Marinkovic, Zoran S., Sánchez-Rivera, Francisco J., Leach, Steven D. et al. · 2019 · Nature
  28. Inhibition of de novo palmitate synthesis by fatty acid synthase induces apoptosis in tumor cells by remodeling cell membranes, inhibiting signaling pathways, and reprogramming gene expression
    Ventura, Richard, Mordec, Kasia, Waszczuk, Joanna, Wang, Zhaoti, Lai, Julie, Fridlib, Marina, Buckley, Douglas, Kemble, George, Heuer, Timothy S. · 2015 · EBioMedicine
  29. Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung Tumorigenesis
    Mahesh S. Padanad, Georgia Konstantinidou, Niranjan Venkateswaran, Margherita Melegari, Smita Rindhe, Matthew A. Mitsche, Chendong Yang, Kimberly G. Batten, Kenneth E. Huffman, Jingwen Liu et al. · 2016 · Cell Reports
  30. Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters
    Marchiq, Ibtissam, Pouysségur, Jacques · 2016 · Journal of Molecular Medicine
  31. Physical Principles of Membrane Shape Regulation by the Glycocalyx
    Carolyn R. Shurer, Joe Chin‐Hun Kuo, LaDeidra Monét Roberts, Jay G. Gandhi, Marshall J. Colville, Thais A. Enoki, Hao Pan, Jin Su, Jade M. Noble, Michael J. Hollander et al. · 2019 · Cell
  32. SIRT6 suppresses pancreatic cancer through control of Lin28b
    Sita Kugel, Carlos Sebastián, Julien Fitamant, K. Ross, S. Saha, E. Jain, A. Gladden, Kshitij S Arora, Y. Kato, M. Rivera et al. · 2016 · Cell
  33. Metabolic reprogramming in cancer: Mechanisms and therapeutics
    Shiqi Nong, Xiaoyue Han, Xiang Yu, Yuran Qian, Yuhao Wei, Tingyue Zhang, Keyue Tian, Kai Shen, Jing Yang, Xuelei Ma · 2023 · MedComm
  34. O-GlcNAc Transferase Integrates Metabolic Pathways to Regulate the Stability of c-MYC in Human Prostate Cancer Cells
    Harri M. Itkonen, Sarah Jane Pauline Minner, Ingrid Jenny Guldvik, Mareike Julia Sandmann, Maria Christina Tsourlakis, Viktor Berge, Aud Svindland, Thorsten Schlomm, Ian Geoffrey Mills · 2013 · Cancer Research
  35. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice
    Shu‐Heng Jiang, Jun Li, Fang-Yuan Dong, Jian‐Yu Yang, De-Jun Liu, Xiao-Mei Yang, Yahui Wang, Minwei Yang, Xue-Liang Fu, Xiao-Xin Zhang et al. · 2017 · Gastroenterology
  36. Adenovirus E4ORF1-Induced MYC Activation Promotes Host Cell Anabolic Glucose Metabolism and Virus Replication
    Minh Thai, Nicholas Alexander Graham, Daniel Braas, Michael Nehil, Evangelia Komisopoulou, Siavash K. Kurdistani, Frank P. McCormick, Thomas G. Graeber, Heather R. Christofk · 2014 · Cell Metabolism
  37. Fibroblast Heterogeneity in the Pancreatic Tumor Microenvironment
    Erin J. Helms, Maria Kathrina Oñate, Mara H. Sherman · 2020 · Cancer Discovery
  38. Cancer Cells Tune the Signaling Pathways to Empower de Novo Synthesis of Nucleotides
    Elodie Villa, Eunus Sheemul Ali, Umakant Sahu, Issam Ben‐Sahra · 2019 · Cancers
  39. Loss of the Tumor Suppressor LKB1 Promotes Metabolic Reprogramming of Cancer Cells via HIF-1α
    Faubert, Brandon, Vincent, Emma E., Griss, Takla, Samborska, Bozena, Izreig, Said, Svensson, Robert U., Mamer, Orval A., Avizonis, Daina, Shackelford, David B., Shaw, Reuben J. et al. · 2014 · Proceedings of the National Academy of Sciences
  40. Oncogenic KRAS supports pancreatic cancer through regulation of nucleotide synthesis
    Santana-Codina, Naiara, Roeth, Anjali A., Zhang, Yi, Yang, Annan, Mashadova, Oksana, Asara, John M., Wang, Xiaoxu, Bronson, Roderick T., Lyssiotis, Costas A., Ying, Haoqiang et al. · 2018 · Nature Communications
  41. Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer
    Dilly, Julien, Hoffman, Megan T., Abbassi, Laleh, Li, Ziyue, Paradiso, Francesca, Parent, Brendan D., Hennessey, Connor J., Jordan, Alexander C., Morgado, Micaela, Dasgupta, Shatavisha et al. · 2024 · Cancer Discovery
  42. Lipid metabolism and lipophagy in cancer
    Meenu Maan, Jeffrey M. Peters, Mainak Dutta, Andrew D. Patterson · 2018 · Biochemical and Biophysical Research Communications
  43. Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
    Jun Zhao, Xiaofei Wen, Tian Xiang Li, Tingting Li, Chunyu Xu, Xiaoxia Wen, Marites Pasuelo Melancon, Sanjay Kumar Gupta, Baozhong Shen, Weiyi Peng et al. · 2019 · Nature Communications
  44. Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer
    Minru Liao, Dahong Yao, Lifeng Wu, Chaodan Luo, Zhiwen Wang, Jin Zhang, Bo Liu · 2023 · Acta Pharmaceutica Sinica B
  45. Translation control of the immune checkpoint in cancer and its therapeutic targeting
    Xu, Yichen, Poggio, Mauro, Jin, Hyun Yong, Shi, Zhen, Forester, Craig M., Wang, Ying, Stumpf, Craig R., Xue, Lingru, Devericks, Emily, So, Lomon et al. · 2019 · Nature Medicine
  46. O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling
    Christina M. Ferrer, Valerie L. Sodi, Mauricio J. Reginato · 2016 · Journal of Molecular Biology
  47. Tumors and Mitochondrial Respiration: A Neglected Connection
    Andrea Viale, Denise Corti, Giulio Francesco Draetta · 2015 · Cancer Research
  48. Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer
    Dey, Prasenjit, Baddour, Joelle, Muller, Florian, Wu, Chia Chin, Wang, Huamin, Liao, Wen-Ting, Lan, Zangdao, Chen, Alina, Gutschner, Tony, Kang, Yaan et al. · 2017 · Nature
  49. Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches
    Chi Chun Wong, Ying Qian, Jun Qing Yu · 2017 · Oncogene
  50. KRASG12D inhibition reprograms the microenvironment of early and advanced pancreatic cancer to promote FAS-mediated killing by CD8+ T cells
    Mahadevan, Krishnan K., McAndrews, Kathleen M., LeBleu, Valerie S., Yang, Sujuan, Lyu, Hengyu, Li, Bingrui, Sockwell, Amari M., Kirtley, Michelle L., Morse, Sami J., Moreno Diaz, Barbara A. et al. · 2023 · Cancer Cell
  51. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer
    Sampath, Deepak, Zabka, Tanja S., Misner, Dinah L., O’Brien, Thomas, Dragovich, Peter S. · 2015 · Pharmacology & Therapeutics
  52. Mubritinib Targets the Electron Transport Chain Complex I and Reveals the Landscape of OXPHOS Dependency in Acute Myeloid Leukemia
    Irène Baccelli, Yves Gareau, Bernhard Lehnertz, Stéphane Gingras, Jean-François Spinella, Sophie Corneau, Nadine Mayotte, Simon Girard, Mélanie Fréchette, Valérie Blouin-Chagnon et al. · 2019 · Cancer Cell
  53. Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis
    E. Del Poggetto, Iwt Ho, C. Balestrieri, Er-Yen Yen, Shao-Jun Zhang, F. Citron, Rutvij Shah, Denise Corti, G. Diaferia, Chieh-Yuan Li et al. · 2021 · Science
  54. Hyper-O-GlcNAcylation Is Anti-apoptotic and Maintains Constitutive NF-κB Activity in Pancreatic Cancer Cells
    Zhiyuan Ma, David J. Vocadlo, Keith Vosseller · 2013 · Journal of Biological Chemistry
  55. Epithelial–mesenchymal transition in human cancer: Comprehensive reprogramming of metabolism, epigenetics, and differentiation
    Linna Li, Wenliang Li · 2015 · Pharmacology & Therapeutics
  56. Drug resistance in pancreatic cancer: Impact of altered energy metabolism
    Cristoforo Grasso, Gerrit Jansen, Elisa Giovannetti · 2017 · Critical Reviews in Oncology/Hematology
  57. Translational advances in pancreatic ductal adenocarcinoma therapy
    Abdel Nasser Hosein, Stephanie K. Dougan, Andrew J. Aguirre, Anirban Maitra · 2022 · Nature Cancer
  58. Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer
    Eric C. Cheung, Gina M. DeNicola, Colin Nixon, Karen Blyth, Christiaan F. Labuschagne, David Arthur Tuveson, Karen H. Vousden · 2020 · Cancer Cell
  59. The Hexosamine Biosynthesis Pathway: Regulation and Function
    Alysta Paneque, Harvey Fortus, Julia Zheng, Guy Werlen, Estela Jacinto · 2023 · Genes
  60. TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer
    Wan Hua, Peter ten Dijke, Sarantos Kostidis, Martin A. Giera, Marten Hornsveld · 2019 · Cellular and Molecular Life Sciences
  61. Metabolism in physiological cell proliferation and differentiation
    Michalis Agathocleous, William A. Harris · 2013 · Trends in Cell Biology
  62. A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer
    Nina Schönhuber, Barbara Seidler, Kathleen Schuck, Christian Veltkamp, Christina Schachtler, Magdalena Zukowska, Stefan Eser, Thorsten B. Feyerabend, Mariel C. Paul, Philipp Eser et al. · 2014 · Nature Medicine
  63. Molecular Pathogenesis of Pancreatic Cancer
    Grant, T.J., Hua, K., Singh, A. · 2016 · Progress in Molecular Biology and Translational Science
  64. Macropinocytosis: A Metabolic Adaptation to Nutrient Stress in Cancer
    Recouvreux, Maria Victoria, Commisso, Cosimo · 2017 · Frontiers in Endocrinology
  65. The RASopathy Family: Consequences of Germline Activation of the RAS/MAPK Pathway
    Mylène Tajan, Romain Paccoud, Sophie Branka, Thomas Édouard, Armelle Yart · 2018 · Endocrine Reviews
  66. Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment
    Samuel A. Kerk, Thales Y. Papagiannakopoulos, Yatrik Madhukar Shah, Costas Andreas Lyssiotis · 2021 · Nature reviews. Cancer
  67. Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer
    Hobbs, G. Aaron, Baker, Nicole M., Miermont, Anne M., Thurman, Ryan D., Pierobon, Mariaelena, Tran, Timothy H., Anderson, Andrew O., Waters, Andrew M., Diehl, J. Nathaniel, Papke, Bjoern et al. · 2020 · Cancer Discovery
  68. A review of the basics of mitochondrial bioenergetics, metabolism, and related signaling pathways in cancer cells: Therapeutic targeting of tumor mitochondria with lipophilic cationic compounds
    Balaraman Kalyanaraman, Gang Cheng, Micaël Hardy, Olivier Ouari, Marcos López, Joy Joseph, Jacek Zielonka, Michael B. Dwinell · 2017 · Redox Biology
  69. Rational combination therapy with PARP and MEK inhibitors capitalizes on therapeutic liabilities in RAS mutant cancers
    Chaoyang Sun, Yong Fang, Jun Yin, Jian Chen, Zhenlin Ju, Dong Zhang, Xiaohua Chen, Christopher P. Vellano, Kang Jin Jeong, Patrick Kwok‐Shing Ng et al. · 2017 · Science Translational Medicine
  70. The Glycolytic Switch in Tumors: How Many Players Are Involved?
    Li Yu, Xun Chen, Xueqi Sun, Liantang Wang, Shangwu Chen · 2017 · Journal of Cancer
  71. Whole Genome, Whole Population Sequencing Reveals That Loss of Signaling Networks Is the Major Adaptive Strategy in a Constant Environment
    Daniel J. Kvitek, Gavin Sherlock · 2013 · PLoS Genetics
  72. The lncRNA MACC1-AS1 promotes gastric cancer cell metabolic plasticity via AMPK/Lin28 mediated mRNA stability of MACC1
    Yang Zhao, Yajing Liu, Lin Li, Qiong Huang, Wanming He, Shuyi Zhang, Shumin Dong, Zhaowei Wen, Jinjun Rao, Wangjun Liao et al. · 2018 · Molecular Cancer
  73. Is Cancer a Metabolic Disease?
    Hilary A. Coller · 2013 · American Journal Of Pathology
  74. Arginine Methylation of MDH1 by CARM1 Inhibits Glutamine Metabolism and Suppresses Pancreatic Cancer
    Yi-Ping Wang, Wei Zhou, Jian Wang, Xian Huang, Yong Zuo, Tian-Shi Wang, Xue Jun Gao, Yingying Xu, Shaowu Zou, Yingbin Liu et al. · 2016 · Molecular Cell
  75. Cancer Metabolism: Current Understanding and Therapies
    Jessica L. Counihan, Elizabeth A. Grossman, Daniel K. Nomura · 2018 · Chemical Reviews
  76. SIRT3‐dependent GOT2 acetylation status affects the malate–aspartate NADH shuttle activity and pancreatic tumor growth
    Hui Yang, Lisha Zhou, Qian Shi, Yuzheng Zhao, Huaipeng Lin, Mengli Zhang, Shimin Zhao, Yi An Yang, Zhi‐Qiang Ling, Kun‐Liang Guan et al. · 2015 · The EMBO Journal
  77. Metabolic Dependencies in RAS -Driven Cancers
    Alec C. Kimmelman · 2015 · Clinical Cancer Research
  78. Glycolysis and glutaminolysis cooperatively control T cell function by limiting metabolite supply to N-glycosylation
    Lindsey Araujo, Phillip Khim, Haik Mkhikian, Christie Mortales, Michael Demetriou · 2017 · eLife
  79. How Viral and Intracellular Bacterial Pathogens Reprogram the Metabolism of Host Cells to Allow Their Intracellular Replication
    Wolfgang Eisenreich, Thomas Rudel, Jürgen Heesemann, Werner Goebel · 2019 · Frontiers in Cellular and Infection Microbiology
  80. Switching to the cyclic pentose phosphate pathway powers the oxidative burst in activated neutrophils
    Emily C. Britt, Jorgo Lika, Morgan A. Giese, Taylor J. Schoen, Gretchen L. Seim, Zhengping Huang, Pui Y. Lee, Anna Huttenlocher A, Jing Fan · 2022 · Nature Metabolism
  81. Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor Microenvironment
    Dey, Prasenjit, Li, Jun, Zhang, Jianhua, Chaurasiya, Surendra, Strom, Anders, Wang, Huamin, Liao, Wen-Ting, Cavallaro, Frederick, Denz, Parker, Bernard, Vincent et al. · 2020 · Cancer Discovery
  82. Acidosis induces reprogramming of cellular metabolism to mitigate oxidative stress
    Gregory LaMonte, Xiaohu Tang, Julia Ling-Yu Chen, Jianli Wu, Chien‐Kuang Cornelia Ding, Melissa M. Keenan, Carolyn Sangokoya, Hsiu‐Ni Kung, Olga Ilkayeva, László G. Boros et al. · 2013 · Cancer & Metabolism
  83. Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up
    Rushika M. Perera, Nabeel M. Bardeesy · 2015 · Cancer Discovery
  84. MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators
    Afra Z. Daoud, Eoghan J. Mulholland, Grace Cole, Helen O. McCarthy · 2019 · BMC Cancer
  85. Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth
    Andrew Graham Cox, Katie L. Hwang, Kristin Brown, Kimberley Jane Evason, Sebastian Beltz, Allison Tsomides, Keelin O’Connor, Giorgio Giacomo Galli, Dean Yimlamai, Sagar Chhangawala et al. · 2016 · Nature Cell Biology
  86. Tumor Microenvironment‐Enabled Nanotherapy
    Liying Wang, Minfeng Huo, Yu Chen, Jianlin Shi · 2017 · Advanced Healthcare Materials
  87. Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer
    Yao, Wantong, Rose, Johnathon L., Wang, Wei, Seth, Sahil, Jiang, Hong, Taguchi, Ayumu, Liu, Jintan, Yan, Liang, Kapoor, Avnish, Hou, Pingping et al. · 2019 · Nature
  88. Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy
    Sharma, Nikita S., Gupta, Vineet K., Garrido, Vanessa T., Hadad, Roey, Durden, Brittany C., Kesh, Kousik, Giri, Bhuwan, Ferrantella, Anthony, Dudeja, Vikas, Saluja, Ashok et al. · 2019 · Journal of Clinical Investigation
  89. Cancer Metabolism and Elevated O-GlcNAc in Oncogenic Signaling
    Zhiyuan Ma, Keith Vosseller · 2014 · Journal of Biological Chemistry
  90. ERKs in Cancer: Friends or Foes?
    Xavier Deschênes‐Simard, Filippos Kottakis, Sylvain Meloche, Gerardo Ferbeyre · 2014 · Cancer Research
  91. Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer
    Evan C. Lien, Costas Andreas Lyssiotis, Lewis C. Cantley · 2016 · Recent results in cancer research/Recent Results in Cancer Research
  92. Ras and Rap1: A tale of two GTPases
    Seema K. Shah, Ethan J. Brock, Kyungmin Ji, Raymond R. Mattingly · 2018 · Seminars in Cancer Biology
  93. Altered Gene Expression along the Glycolysis–Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer
    Joanna M. Karasinska, James Thomas Topham, Steve E. Kalloger, Gun Ho Jang, Robert Edward Denroche, Luka Culibrk, Laura M. Williamson, Hui‐Li Wong, Michael K.C. Lee, Grainne Mary O'Kane et al. · 2019 · Clinical Cancer Research
  94. Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia
    Daniel Herranz, Alberto Ambesi‐Impiombato, Jessica Sudderth, Marta Sánchez-Martín, Laura Belver, Valeria Tosello, Luyao Xu, Agnieszka A. Wendorff, Mireia Castillo-Martín, J. Erika Haydu et al. · 2015 · Nature Medicine
  95. Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
    Wasko, Urszula N., Jiang, Jingjing, Dalton, Tanner C., Curiel-Garcia, Alvaro, Edwards, A. Cole, Wang, Yingyun, Lee, Bianca, Orlen, Margo, Tian, Sha, Stalnecker, Clint A. et al. · 2024 · Nature
  96. Oncogenic KRAS induces NIX-mediated mitophagy to promote pancreatic cancer
    Humpton, Timothy J., Alagesan, Brinda, DeNicola, Gina M., Lu, Dan, Yordanov, Georgi N., Leonhardt, Carl S., Yao, Melissa A., Alagesan, Priya, Zaatari, Maya N., Park, Youngkyu et al. · 2019 · Cancer Discovery
  97. Metabolic reprogramming of pancreatic cancer mediated by CDK4/6 inhibition elicits unique vulnerabilities
    Franco, Jorge, Balaji, Uthra, Freinkman, Elizaveta, Witkiewicz, Agnieszka K., Knudsen, Erik S. · 2016 · Cell Reports
  98. Epidermal Growth Factor Receptor (EGFR) Signaling Regulates Global Metabolic Pathways in EGFR-mutated Lung Adenocarcinoma
    Hideki Makinoshima, Masahiro Takita, Shingo Matsumoto, Atsushi Yagishita, Satoshi Owada, Hiroyasu Esumi, Katsuya Tsuchihara · 2014 · Journal of Biological Chemistry
  99. Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation
    Andrea E. Calvert, Alexandra Chalastanis, Yongfei Wu, Lisa Hurley, Fotini M. Kouri, Yingtao Bi, Maureen T. Kachman, Jasmine May, Elizabeth T. Bartom, Youjia Hua et al. · 2017 · Cell Reports
  100. Targeting Protein-Protein Interaction by Small Molecules
    Jin, Lingyan, Wang, Weiru, Fang, Guowei · 2014 · Annual Review of Pharmacology and Toxicology